Riskpilot← Back to searchSign inGet full accessStrike Pharma AB
ABActiveOrg 5592842651Scheeletorget 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 202010-19 employees
Revenue 2024
SEK 0
EBITDA margin
—
+56% vs 2023
Equity ratio
69.6%
Financial strength
Net profit 2024
SEK -14,2M
+55% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -13,7M | +56% |
| Net profit | SEK -14,2M | +55% |
| Total assets | SEK 11,6M | -17% |
| Equity | SEK 8,1M | -16% |
| Employees | — | — |
Legal name
Strike Pharma AB
Org number
5592842651
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 november 2020
Share capital
SEK 348 982
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva läkemedelsutveckling och medicinsk forskning, sälja tillhörande tjänster och produkter samt bedriva därmed förenlig verksamhet.
Address
Scheeletorget 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | −2 309 |
| EBITDA | −4 644 | −23 602 | −31 292 | −13 745 |
| Depreciation & amort. | −0 | −0 | −0 | — |
| EBIT | −4 644 | −23 602 | −31 292 | −13 745 |
| Net financials | — | — | −412 | −444 |
| Profit before tax | −4 644 | −23 602 | −31 704 | −14 189 |
| Tax | −0 | −0 | −0 | — |
| Net profit | −4 644 | −23 602 | −31 704 | −14 189 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 6 139 | 33 537 | 14 000 | 11 637 |
| Equity | 5 039 | 27 516 | 9 612 | 8 100 |
| Long-term debt | 0 | 0 | 0 | — |
| Short-term debt | 1 100 | 6 021 | 4 387 | 3 537 |
| Total debt | 1 100 | 6 021 | 4 387 | 3 537 |
EBITDA margin
-1374484300.0%
This company
15.8%
Market median
-8699267822% vs market
20212024
Equity ratio
69.6%
This company
38.2%
Market median
+82% vs market
20212024
Return on equity
-175.2%
This company
18.4%
Market median
-1052% vs market
20212024
Net profit margin
-1418865900.0%
This company
8.1%
Market median
-17516863063% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
JF Chief Auditor | Chief Auditor | 2022 | — | — |
PG Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Strike Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mårten Winge | Chief Executive Officer | 0 companies |
| Jonas Fredrik Mårtensson | Chief Auditor | 0 companies |
| Per Göran Oskar Norlén | Chief Executive Officer | 0 companies |
| Ylva Gunilla Ekström | Board of Directors | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Pierre Robert Dönnes | Chairman | 0 companies |
| Patrik Strömberg | Board of Directors | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Johan Sven Erik Rockberg | Board of Directors | 0 companies |
| Björn Johan Niclas Stjernholm | Chairman | 0 companies |
| Sara Maria Mangsbo | Board of Directors | 0 companies |
| John Allan Asp | Board of Directors | 0 companies |
| Gunnar Magnus Severus Persson | Chairman | 0 companies |
| Karl Ola Elmqvist | Board of Directors | 0 companies |
| Chris Wing-Shing Cheng | Board of Directors | 0 companies |
| Gunilla Ingeborg O Lundmark | Chairman | 0 companies |
| Michael Sacha Akhras | Board of Directors | 0 companies |
| Maarten De Chateau | Board of Directors | 0 companies |